You are here

  • Home
  • Archive
  • Volume 18, Issue 3
  • The cardiovascular risk of azithromycin was increased in a large observational cohort study, contradicting findings from prior randomised trials

Article info

Article menu
Download PDFPDF
Prognosis
Cohort study
The cardiovascular risk of azithromycin was increased in a large observational cohort study, contradicting findings from prior randomised trials

Authors

  1. Correspondence to : Dr Joseph Brent Muhlestein
    Department of Cardiology, IMC, 5121 S Cottonwood Street, Murray, UT 84107, USA; Brent.Muhlestein{at}imail.org
View Full Text

Citation

Muhlestein JB
The cardiovascular risk of azithromycin was increased in a large observational cohort study, contradicting findings from prior randomised trials
BMJ Evidence-Based Medicine 2013;18:e28.

Publication history

  • First published September 5, 2012.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions